Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by ipanemaon Jul 23, 2017 11:40am
158 Views
Post# 26499115

Comparisons CGC and APH

Comparisons CGC and APHI thought I would share some of my analysis metrics with the Board in part to see if I have made some errors so please provide input if the numbers are incorrect.

Comparisons   Year Year
      APH WEED
Gross Margin before Fair Value ADJ 77.57% 63.15%
Fair Market Adj as a % of Revenues 7.06% 31.18%
Gross Margin with IRRF   84.63% 94.33%
         
Operational Costs as a % of Revenues    
General and Admin   22.89% 42.26%
Share based Compensation   11.74% 20.17%
Selling MKT and Promotion   32.60% 32.49%
Amortization   4.68% 15.20%
Research and development   2.41% 2.03%
      74.32% 112.14%
         
Increase in Biologial Assets in Period $664,752 $8,322,000
         
Inventory increase in KGS during period 530 4,161
Sales in KGS in Period   2,615 5,139
         
Valuation  per Gram of Dry Cannabis in Inventory $3.75 $5.26
Valuation per ml of Oil in Inventory $0.62 $2.49
         
Average Sales Price per gram   $7.82 $7.76
         
Average cost per Gram in period $1.87 $2.86
         
Average profit per gram on Sale $4.07 $2.50
Period IFRS mark up per gram   $1.88 $2.40
Total Gross Margin   $5.95 $4.90
         
 Kilos in closing inventory   991 8,665
 Kilos sold in last quarter   738 1,740

Bullboard Posts